<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03509740</url>
  </required_header>
  <id_info>
    <org_study_id>dysmenorrhea</org_study_id>
    <nct_id>NCT03509740</nct_id>
  </id_info>
  <brief_title>Intravenous Tramadol Versus Intravenous Paracetamol in Patients With Dysmenorrhea</brief_title>
  <official_title>Comparing Efficiencies of Intravenous Paracetamol and Intravenous Tramadol in Patients With Primary Dysmenorrhea Presented in Emergency Department</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients presented with primary dysmenorrhea composed the study population. One gram
      paracetamol and 100 mg tramadol in 100 ml saline with a slow infusion were compared in
      ceasing dysmenorrhea in the emergency department
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients over 18 years old who presented with dysmenorrhea composed the study population.
      Patients received painkiller within the last six hours, physical findings consistent with
      peritoneal irritation, allergy to the study drugs, renal or liver failure, drug addiction,
      pregnancy or woman with lactation and denied to give inform consent were the exclusion
      criteria. The pain of the study patients is measured with the visual analogue scale at
      baseline, 15th and 30th minutes and 1 hour after study drug administration. At the end of the
      60 minutes, rescue drug need is also recorded.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 25, 2018</start_date>
  <completion_date type="Anticipated">October 10, 2018</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>acute pain of dysmenorrhea measured by visual analogue scale</measure>
    <time_frame>15 minutes</time_frame>
    <description>Change in visual analogue scale at 15th minutes from baseline</description>
  </primary_outcome>
  <primary_outcome>
    <measure>pain of dysmenorrhea measured by visual analogue scale</measure>
    <time_frame>30 minutes</time_frame>
    <description>Change in visual analogue scale at 30th minutes from baseline</description>
  </primary_outcome>
  <primary_outcome>
    <measure>pain of dysmenorrhea measured by visual analogue scale</measure>
    <time_frame>60 minutes</time_frame>
    <description>Change in visual analogue scale at 60th minutes from baseline</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rescue drug need</measure>
    <time_frame>60 minutes.</time_frame>
    <description>the need for additional analgesic drug</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>adverse effects.</measure>
    <time_frame>60 minutes</time_frame>
    <description>nausea and dizziness</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Dysmenorrhea</condition>
  <arm_group>
    <arm_group_label>tramadol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intravenous 100 mg tramadol in 100 ml saline with slow infusion.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>paracetamol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intravenous 1 gm paracetamol in 100 ml saline with slow infusion.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>tramadol</intervention_name>
    <description>100 mg tramadol in 100 ml saline with slow infusion</description>
    <arm_group_label>tramadol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>paracetamol</intervention_name>
    <description>Intravenous 1 gm paracetamol in 100 ml saline with slow infusion</description>
    <arm_group_label>paracetamol</arm_group_label>
    <other_name>perfalgan</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with dysmenorrhea

          -  Patients over 18 years old

        Exclusion Criteria:

          -  denied to give inform consent

          -  Renal or liver failure

          -  Allergy to the study drugs

          -  Receiving pain killer within the last 6 hours.

          -  Physical examination findings consistent with peritoneal irritation

          -  Pregnancy or patients with lactation

          -  Drug addiction
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>AHMED SAMY, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cairo University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>AHMED SAMY, MD</last_name>
    <phone>00201100681167</phone>
    <email>ahmedsamy8233@gmail.com</email>
  </overall_contact>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 17, 2018</study_first_submitted>
  <study_first_submitted_qc>April 25, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 26, 2018</study_first_posted>
  <last_update_submitted>April 25, 2018</last_update_submitted>
  <last_update_submitted_qc>April 25, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 26, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Ahmed Samy aly ashour</investigator_full_name>
    <investigator_title>lecturer in obstetrics and gynecology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dysmenorrhea</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Tramadol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

